April 3, 2025 - 15:10

US stock futures plunged dramatically after President Donald Trump declared a 10% tariff on all trading partners, creating turmoil in financial markets and raising concerns about the global trade landscape. The announcement has led to widespread apprehension among investors, with projections indicating a potential drop of over 1,000 points for the Dow Jones Industrial Average.
The S&P 500 and Nasdaq are also expected to experience significant declines as the implications of the tariffs ripple through various sectors. Analysts warn that this move could escalate trade tensions and provoke retaliatory measures from other countries, further destabilizing the already fragile global economy.
Market participants are bracing for a turbulent trading session as they assess the potential fallout from this decision. With uncertainty looming, many investors are reconsidering their strategies, leading to a flight to safer assets. The impact of these tariffs could be felt far beyond US borders, affecting economies and markets worldwide.
May 17, 2026 - 08:31
How Investors Are Reacting To NVE (NVEC) Steady Earnings And Maintained Quarterly DividendNVE Corporation has released its full-year results for the period ending March 31, 2026, posting revenue of US$26.33 million and net income of US$15.2 million. The company also confirmed a...
May 16, 2026 - 22:25
Risky Integration or Rewarding Returns? The Stakes of SoundHound's LivePerson Acquisition.SoundHound AI`s acquisition of LivePerson is drawing mixed reactions from investors, with the immediate fallout hitting the stock price. The deal, which combines SoundHound`s voice AI technology...
May 16, 2026 - 10:38
Bank of Hawaii, Glacier Bancorp, and Wintrust Financial Shares Plummet, What You Need To KnowShares of several regional banks took a sharp hit in afternoon trading Wednesday after the latest inflation report came in hotter than expected. The April Consumer Price Index rose 3.8%, a figure...
May 15, 2026 - 17:39
Plus Therapeutics Shares First Quarter 2026 Financial Results and Updates on REYOBIQ and CNSide ProgressHOUSTON, May 15, 2026 -- Plus Therapeutics, a healthcare company focused on precision diagnostics and radiopharmaceuticals for central nervous system cancers, reported its financial results for the...